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Saavedra, Juan M., Walter Häuser, Gladys Ciuffo,
Giorgia Egidy, Kwang-Lae Hoe, Olaf Jöhren, Takaaki
Sembonmatsu, Tadashi Inagami, and Inés Armando.
Increased AT1 receptor expression and mRNA in kidney
glomeruli of AT2 receptor gene-disrupted mice. Am J Physiol
Renal Physiol 280: F71–F78, 2001.—The proposed feedback
between angiotensin II AT2 and AT1 receptors prompted us
to study AT1 receptor expression in kidneys of male AT2
receptor-gene disrupted mice (agtr2 2/y). In wild-type (agtr2
1/y) mice, AT1 receptor binding and mRNA is abundant in
glomeruli, and AT1 receptor binding is also high in the inner
stripe of the outer medulla. AT2 receptors are scarce, primar-
ily associated to cortical vascular structures. In agtr2 2/y
mice, AT1 receptor binding and mRNA were increased in the
kidney glomeruli, and AT1 receptor binding was higher in the
rest of the cortex and outer stripe of the outer medulla, but
not in its inner stripe, indicating different cellular regula-
tion. Although AT2 receptor expression is very low in male
agtr 2 1/y mice, their gene disruption alters AT1 receptor
expression. AT1 upregulation alone may explain the AT2
gene-disrupted mice phenotype such as increased blood pres-
sure, higher sensitivity to angiotensin II, and altered renal
function. The indirect AT1/AT2 receptor feedback could have
clinical significance because AT1 antagonists are widely used
in medical practice.
renin-angiotensin system; angiotensin II receptor types;
gene-disrupted models
ANGIOTENSIN II (ANG II), by stimulation of specific,
discretely localized ANG II receptors, plays a crucial
role in the modulation of renal function in mammals
(31). ANG II receptors are classified into AT1 and AT2
types on the basis of their relative affinity for nonpep-
tidic-selective ligands (46) and molecular cloning (16,
19, 39). Most of the known actions of ANG II on the
regulation of water and salt metabolism are dependent
on stimulation of AT1 receptors (31, 46). In the kidney,
stimulation of AT1 receptors by ANG II modulates both
glomerular and tubular function including sodium re-
tention, vasoconstriction of renal vessels, and de-
creased glomerular filtration rate (2).
AT1 receptors are present in large numbers in the
adult mammalian kidney, with a major expression in
the glomeruli, and lower levels in the renal cortical
tubules, vasculature, medullar interstitial cells, and
collecting ducts (1, 4, 6, 22, 23, 30, 36, 38, 40). Of the
two AT1 receptor subtypes existing in rodents, AT1A
and AT1B, the AT1A receptors predominate in the kid-
ney (22). In adult rodents, kidney AT2 receptors were
reported to be absent (4, 23, 41) or present at low levels
(18, 38). Other studies reported a selective association
of AT2 receptors in the adult kidney from different
species, including humans, with vascular structures (8,
9, 10, 30, 49). The localized and restricted expression of
AT2 receptors in association with renal arteries
strongly suggested a function of AT2 receptors different
from that of AT1 receptors, perhaps related to inhibi-
tion of angiogenesis and vasodilation (3, 34).
The availability of animal models with targeted dis-
ruption of specific genes provided an opportunity to
further analyze the possible role of AT2 receptors. The
targeted disruption of the mouse AT2 receptor gene
significantly increased blood pressure and the sensitiv-
ity to the pressor action of ANG II, indicating an
enhanced response to AT1 receptor stimulation (15,
17). We asked the question whether absence of AT2
receptor transcription could result in alterations in
AT1 receptor binding or mRNA expression in selected
areas of the kidney in this mouse model.
MATERIALS AND METHODS
Animals. Mice were obtained form the Department of
Biochemistry, Nashville University, and were kept under
controlled conditions with free access to water and food,
according to protocols approved by National Institute of Men-
tal Health (NIMH) Animal Care and Use Committee. We
produced the agtr2 gene-disrupted mice by the injection of
agtr2 disrupted embryonic stem cells (E14–1) from the 129
Ola mouse line into blastocyts derived from C57BL/6 mice, as
described previously (17). After the genotype of F2 heterozy-
gous females (agtr2 2/1) was clearly confirmed, they were
backcrossed with C57BL/6 wild-type males for three genera-
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tions. Littermate gene-disrupted (agtr2 2/Y) and control
wild-type (agtr2 1/Y) males were selected from the third
backcross progeny to minimize the effect of differences in
genetic background.
Mice were transported to NIMH, kept for 1 day under
controlled conditions as above, and killed by decapitation
between 10:00 AM and 11:00 AM. Kidneys were immediately
removed, frozen in isopentane at 230°C, and stored at
280°C. For binding studies, sections (16 mm) were cut in a
cryostat at 220°C, thaw-mounted on gelatin-coated slides,
and dried overnight in a desiccator at 4°C. Sections were
stored at 280°C until binding experiments were performed.
Consecutive sections were used for ANG II receptor binding
studies and in situ hybridization. Every tenth section was
stained with hematoxylin and eosin to localize the structures
expressing the binding or the receptor mRNA. For in situ
hybridization experiments, sections were collected on si-
lanated glass slides (Digene Diagnostics, Beltsville, MD) and
stored at 280°C.
ANG II receptor binding. Sar1-ANG II (Peninsula Labora-
tories, Belmont, CA) and CGP-42112 (Neosystems Labora-
tory, Strasbourg, France) were iodinated by New England
Nuclear (Boston, MA) to a specific activity of 2,200 Ci/mmol.
Adjacent kidney sections were preincubated for 15 min at
22°C in 10-mM sodium phosphate buffer, pH 7.4, containing
120 mM NaCl, 5 mM EDTA, 0.005% bacitracin (Sigma, St.
Louis, MO), and 0.2% protease-free BSA (Sigma), followed by
incubation for 2 h at 22°C in fresh buffer, prepared as above
with the addition of 50 mM Plummer’s inhibitor (Calbiochem,
La Jolla, CA), 100 mM phenylmethylsulfonyl fluoride (Sig-
ma), 500 mM phenantrolin (Sigma), and 0.5 nM [125I]Sar1-
ANG II. After an incubation for 120 min at 22°C the sections
were washed four times for 1 min each in ice-cold 50 mM
Tris-HCl buffer (pH 7.4), followed by a 30 s wash in ice-cold
water, and dried under a stream of cold air.
Binding of [125I]Sar1-ANG II to AT1 receptors was deter-
mined in adjacent kidney sections as follows. Some sections
were incubated with 0.5 nM [125I]Sar1-ANG II to determine
total binding. Adjacent sections were incubated as above
with the addition of 1025 M losartan (DuPont-Merck, Wil-
mington, DE), to displace binding to AT1 receptors. Binding
to AT1 receptors was calculated as the difference between
total binding and the binding remaining in adjacent sections
incubated in the presence of excess concentration of losartan.
Similarly, binding of [125I]Sar1-ANG II to AT2 receptors was
determined as the difference between total binding and bind-
ing in adjacent sections incubated in the presence of 1026 M
of PD-123319 (Parke-Davis, Ann Arbor, MI) to selectively
displace binding to AT2 receptors. The concentrations of the
AT1 and AT2 receptor-selective ligands were selected to give
maximum-specific displacement (13). Nonspecific or back-
ground binding was determined by incubating consecutive
sections with 1026 M ANG II (Peninsula). The values re-
maining were subtracted from all determinations as de-
scribed above. In the case of areas where we found binding
only to AT1 receptors, the values obtained after displacement
with excess concentrations of losartan were not significantly
different from background values obtained by displacement
with excess concentrations of unlabeled ANG II.
In addition, [125I]CGP-42112 binding was performed in
another set of adjacent sections to confirm the presence or
absence of AT2 receptors. At the concentrations used,
[125I]CGP-42112 exclusively labels AT2, and not AT1, recep-
tors (14). Buffers used in this assay had the same composi-
tion as those used for the binding with [125I]Sar1-ANG II.
Tissue sections were preincubated for 15 min in incubation
buffer followed by incubation for 120 min in fresh buffer
containing 0.2 nM [125I]CGP-42112. To determine specific
binding to AT2 receptors, consecutive sections were incu-
bated in the presence of 1026 M of PD-123319 to selectively
displace binding to AT2 sites. Nonspecific binding was deter-
mined by incubating consecutive sections with 5 3 1026 M of
ANG II (Peninsula).
To further localize AT2 receptors histologically, [
125I]CGP-
42112 binding was performed in 6-mm thick kidney sections.
Adjacent sections were stained with hematoxylin and eosin.
After binding experiments, sections were fixed for 60 min in
paraformaldehyde vapors at 80°C and dipped in photo emul-
sion. After exposure for 2 wk, sections were developed in
Kodak D-19 developer for 3 min at 15°C, fixed for 4 min, and
counter stained with hematoxylin and eosin.
To determine if the radio-labeled ligands could be signifi-
cantly metabolized under the conditions of incubation, we
analyzed aliquots of buffers obtained before and after incu-
bation of kidney sections by reversed-phase high perfor-
mance liquid chromatography as described earlier (13). No
metabolism of the radio-labeled ligands was observed under
the above-mentioned conditions (results not shown).
Quantitative receptor autoradiography. We exposed dry
sections to Hyperfilm-3H (Amersham, Arlington Heights, IL)
along with 16-mm sections of autoradiographic 125I mi-
croscales (Amersham) at 4°C. Films were developed in ice-
cold D-19 developer (Eastman Kodak, Rochester, NY) for 4
min, fixed in Kodak rapid fixer for 4 min at 22°C, and rinsed
in water for 15 min. We measured optical densities in the
autoradiograms by computerized microdensitometry by us-
ing the NIH Image 1.6 analysis system (NIMH, Bethesda,
MD). For quantitative autoradiography, we measured the
optical densities separately in kidney glomeruli, the rest of
the cortex, and outer and inner stripes of the outer medulla.
The optical densities were related to the concentration of
radioactivity present in the sections by comparison with the
125I microscales, and transformed to corresponding values of
fmol/mg protein (37). These values should be considered as
arbitrary units, because the ligand concentrations used are
below saturation, and because the actual protein-tissue-pro-
tein concentration varies between the different regions of the
kidney (37). We found similar differences between groups
when values were calculated as optical densities before com-
parison to 125I standards.
In situ hybridization histochemistry. In situ hybridization
was performed by using 35S-labeled antisense and sense
(control) riboprobes (21). A 478-bp EcoR I/SacI cDNA frag-
ment of rat AT1A receptor (19, 39) showing 95 and 88%
sequence homology to the mouse AT1A and AT1B receptor
cDNA, respectively, and 99.4 and 92.5% amino acid homology
to mouse AT1A and AT1B receptors, respectively (19, 39), was
subcloned into the pBluescript II KS1 vector. Riboprobes
were labeled by in vitro transcription by using an RNA
labeling kit (Amersham). Because we used a riboprobe to the
coding region of the rat AT1 receptor that has a very high
homology between AT1A and AT1B-rodent subtypes, we did
not determine the relative contribution of kidney AT1A or
AT1B receptor subtypes in our experiments. However, over
95% of the renal AT1 receptors are of the AT1A subtype (22).
Thus the mRNA data presented here predominantly reflects
the regulation of the AT1A receptors.
Sections were fixed in 4% paraformaldehyde for 10 min,
acetylated for 10 min in 0.1 M triethanolamine HCl, pH 8.0,
containing 0.25% acetic anhydride, dehydrated in alcohols,
and air dried. Each section was covered with 50-ml hybrid-
ization buffer containing 50% formamide, 0.3 M NaCl, 2 mM
EDTA, 20 mM Tris, pH 8.0, 1 3 Denhardt’s solution, 10%
dextran sulfate, 100 mg/ml salmon sperm DNA, 250 mg/ml
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yeast tRNA, 150 mM DTT, 0.1% SDS, and 40,000-counts per
minute/ml sense or antisense probe. Sections were hybridized
overnight at 54°C, treated with 40 mg/ml RNase A (Sigma, St.
Louis, MO) for 30 min, and washed in sodium chloride/
sodium citrate (SSC) with increasing stringency. After a final
wash in 0.1 3 SSC at 65°C for 60 min, sections were dehy-
drated through alcohols and exposed to Hyperfilm-3H (Am-
ersham) along with 14C microscales (Amersham) for 7 days.
Films were developed as described above. The intensities of
hybridization signals in kidney glomeruli, the rest of the
cortex, and outer and inner stripes of the outer medulla, were
quantified as nCi/g tissue equivalent by measuring optical
film densities by using the NIH Image 1.61 program. Data
were calibrated with 14C microscales after subtraction of the
values obtained in the same areas of adjacent sections hy-
bridized with sense (control) probes (nonspecific hybridiza-
tion). The values obtained represent arbitrary units, because
the protein content or weight of the different kidney areas
may be different (32). We found similar differences between
groups when values were calculated as optical densities be-
fore comparison to 14C standards.
For cellular localization, slides were dipped in Kodak
NTB2 photo emulsion, exposed for 4 wk, developed in Kodak
D-19 developer for 3 min at 15°C, fixed for 4 min, and
counterstained with hematoxylin and eosin (Fisher Scien-
tific, Fair Lawn, NJ).
Statistical analysis. Results were expressed as means 6
SE, calculated and analyzed by using GraphPad Prism (ver-
sion 2.00) and Microsoft Excel (version 7.0a). Statistical anal-
ysis for values obtained from the displacement studies by
using single concentrations of the displacers was performed
by using a one-way ANOVA followed by post hoc analysis
with the Newman-Keuls multiple comparison test. Mean 6
SE values of wild-type and AT2 gene-disrupted mice were
compared for significance by using unpaired Student’s t-test.
RESULTS
ANG II receptor subtype expression and mRNA in
wild-type mice. We studied ANG II receptor subtype
binding and mRNA in the kidney of male wild-type and
AT2 gene-disrupted mice. Binding to AT1 receptors
was, as expected, high and selectively localized in the
kidney of wild-type mice. In wild-type mice, the highest
levels of losartan-sensitive, PD-123319-insensitive,
[125I]Sar1-ANG II binding to AT1 receptors were
present on glomeruli (Fig. 1, A-E) and lower levels in
the inner stripe of the outer medulla (Table 1). Binding
to AT1 receptors was also present in the rest of the
cortex and the outer stripe of the outer medulla (Ta-
ble 1).
Emulsion autoradiography in wild-type mice re-
vealed very high losartan-sensitive [125I]Sar1-ANG II
binding in kidney glomeruli and low, diffuse losartan-
sensitive binding throughout the whole renal cortex
(Fig. 2, A-C).
AT1 receptor mRNA was also detected in the kidney
of male wild-type mice. As it was the case with AT1
receptor binding, AT1 receptor mRNA was higher in
the glomeruli, and lower in the rest of the cortex and in
the outer and inner stripes of the outer medulla (Table
1 and Fig. 3, A and B). Low levels of AT1 mRNA
expression were located in the renal vasculature (Fig.
3C).
In some cortical structures of wild-type mice, of
different shape and size than the glomeruli, we
found high-losartan-insensitive, PD-123319-sensi-
tive [125I]Sar1-ANG II binding, indicative of AT2 re-
Fig. 1. Autoradiography of ANG II receptor type binding in kidneys from male mice. Hematoxylin-eosin (H & E)
staining [wild-type (A), AT2 gene deficient (F)] and autoradiographs with binding of 0.5 nM [
125I]Sar1-ANG II in
kidneys of wild-type (1/y) mice (B-E) and AT2 receptor gene-disrupted (-/y) mice (G-J) alone (B, G) or in the
presence of 1026 M ANG II (C, H ), 1025 M losartan (D, I ), and 1026 PD-123319 (E, J ). Scale bar, 1 mm. Arrows
point to losartan-sensitive [125I]Sar1-ANG II binding to AT1 receptors located on glomeruli. Arrowheads point to
losartan-insensitive [125I]Sar1-ANG II binding to AT2 receptors that are absent in AT2 receptor gene-disrupted
mice (I ).
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ceptors (Fig. 1D). To confirm the presence of AT2
receptors in the cortical structures distinct from glo-
meruli, we used AT2 receptor-selective [
125I]CGP-
42112 binding (Fig. 4). All [125I]CGP-42112 binding
was displaced by ANG II (Fig. 4B) and by the AT2
receptor-specific ligand PD-123319 (Fig. 4D) but not
by the AT1 receptor-specific ligand losartan (Fig. 4C).
Specific [125I]CGP-42112 binding sites were detected
in the kidney cortex and, as determined by emulsion
autoradiography, were associated only with vascular
structures, in particular the arcuate arteries (Fig. 2,
D and E). Emulsion autoradiographic analysis of
other structures in the kidney cortex, and in partic-
ular the kidney glomeruli, did not reveal accumula-
tion of silver grains above background levels.
ANG II AT1 receptor expression and mRNA in AT2
gene-disrupted mice. As expected, the AT2 receptor
gene-disrupted male did not express losartan-insensi-
tive, PD-123319-sensitive (AT2) [
125I]Sar1-ANG II
binding sites (Fig. 1, F-J) or AT2 receptor-selective
[125I]CGP-42112 binding (Fig. 4, E-H) in the renal
cortex or in other areas of the kidney.
Table 1. ANG II receptor AT1 binding and mRNA
in mouse kidney
Wild-Type AT2 Gene-Disrupted %Change
Glomeruli
Binding 72619 16465† 1127
mRNA 456645 695663† 152
Rest of the cortex
Binding 964 2765* 1200
mRNA 93631 134632 144
Outer stripe of the
outer medulla
Binding 861 1562* 187
mRNA 106612 166627 156
Inner stripe of the
outer medulla
Binding 2966 2863 24
mRNA
Values are means 6 SE. Binding to ANGII type 1 (AT1) receptors,
as determined by quantitative autoradiography, is expressed in
fmol/mg protein. AT1 receptor mRNA, determined by in situ hybrid-
ization, is expressed in nCi/g. *P , 0.05; †P , 0.001, statistically
significant differences between wild-type and AT2 gene-disrupted
mice.
Fig. 2. Emulsion autoradiography of binding to AT1 and AT2
receptors in kidneys from male mice. Emulsion autoradiographs of
binding of 0.5 nM [125I]Sar1-ANG II to glomeruli of kidneys from
AT2 receptor gene-disrupted (-/y) mice in the absence (B) and
presence of 1025 M losartan (C). In addition, [125I]CGP-42112
binding is shown in vascular structures of kidneys from wild-type
(1/y) mice (E). A and D: histology of B and E, respectively. A and
D: arrows point to glomeruli. D and E: arrowheads point to a blood
vessel. Scale bars, 60 mm. Scale bar in A applies to A-C. Scale bar
in D applies to D and E.
Fig. 3. Autoradiography of ANG II receptor subtype mRNA in kid-
neys from male mice. Film (A and B) and emulsion (C) autoradio-
grams after in situ hybridization by using an AT1 receptor-specific
riboprobe. A: wild-type mice. B: AT2 gene-disrupted mice. Note the
presence of AT1 receptor mRNA in glomeruli from wild-type mice
(arrow in C). C: arrowhead points to a blood vessel. Scale bar in A is
2 mm (also applies to B). Scale bar in C is 250 mm.
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A remarkable difference in ANG II AT1 receptor
binding studied with quantitative autoradiography,
and mRNA, as determined by in situ hybridization,
was noted in AT2 gene-disrupted mice compared with
wild-type controls. In AT2 receptor gene-disrupted
mice, both [125I]Sar1-ANG II binding to AT1 receptors
and AT1 receptor mRNA were higher compared with
values in wild-type mice. Significant increases in AT1
receptor binding (;125%) (Table 1, Fig. 1, G and J ) and
AT1 mRNA (;50%) (Table 1, Fig. 3, B and C) were
found in glomeruli.
Binding was significantly increased in the rest of the
renal cortex (3-fold) and in the outer stripe of the outer
medulla (;90%). In these areas there was a tendency
toward increased expression of AT1 mRNA, a ;45%
increase in the rest of the renal cortex, and about a
;55% increase in the outer stripe of the outer medulla
(Table 1).
In the rest of the renal cortex and the outer stripe of
the outer medulla of AT2 gene-disrupted mice, AT1
receptor expression was also significantly higher (Ta-
ble 1). In these areas there was increased expression of
AT1 mRNA, but the results did not achieve statistical
significance (Table 1). Conversely, no significant differ-
ences were found in AT1 receptor binding or mRNA in
the inner stripe of the outer medulla between wild-type
animals and AT2 gene-deficient male mice (Table 1).
DISCUSSION
We report that gene disruption of the ANG II AT2
receptor results in marked and selective alterations on
the protein and mRNA expression of the renal AT1
receptors in the male mouse.
First, we analyzed the distribution of AT1 receptor
binding and mRNA in the kidney of wild-type male
mice. The highest numbers of AT1 receptors and high-
est AT1 mRNA expression occur in the glomeruli, sig-
nificant AT1 receptor binding, and mRNA in the inner
stripe of the outer medulla, and lower binding and
receptor mRNA in the rest of the kidney cortex. These
results are in agreement with previous data from other
mammalian species and with the demonstration of AT1
receptors, not only in glomeruli but also in proximal
and distal tubules, medullar interstitial cells, and the
vasculature (1, 4, 6–10, 22, 23, 30, 36, 38, 40, 48). In
addition, we detected low levels of AT1 receptor bind-
ing, and significant levels of AT1 receptor mRNA, in
the outer stripe of the outer medulla of wild-type mice.
This indicates that some AT1 receptors may be located,
in the mouse, in medullar structures that do not ex-
press AT1 receptors in the rat (47).
We found a clear expression of AT2 receptor binding
in the kidney of the wild-type mice, a finding that again
contrasts with the reported absence of AT2 receptors in
adult rats (1, 4, 5). The number of AT2 receptors in the
adult mouse kidney was much lower than that of AT1
receptors, and followed a different pattern of localiza-
tion. AT2 receptor binding was restricted to very selec-
tive cortical areas associated with renal vessels. This is
in agreement with the reported localization of AT2
receptors in renal vessels of other species, including
humans (8, 9, 10, 30, 48). Under the conditions of our
assay, we could not find AT2 receptor binding in kidney
glomeruli and interstitial cells, as proposed with im-
munocytochemical techniques (38). If present, these
receptors might be expressed in low amounts below the
sensitivity of our assay.
Thus our analysis of ANG II receptor subtypes in the
adult mice indicated that both receptors were clearly
expressed, that the AT1 receptor predominated, and
that the localization of the receptor subtypes occurred,
at least for the most part, with exception of the vascu-
lature, in separate renal structures.
Fig. 4. Autoradiography of binding to
AT2 receptors in kidneys from male
mice. Binding of 0.2 nM [125I]CGP-42112
in kidneys of wild-type (1/y) mice (A-D)
and AT2 receptor gene-disrupted (-/y)
mice (E-H ) alone (A, E) and in the pres-
ence of 5 3 1026 ANG II (B, F), 1025 M
losartan (C, G), and 1026 PD-123319 (D,
H). Arrowheads point to specific binding
of [125I]CGP-42112 to AT2 receptors.
Scale bar, 1 mm (A-H).
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Next, we studied ANG II receptor subtype expres-
sion and mRNA in AT2 gene-disrupted mice. In the
kidney of adult AT2 gene-disrupted mice there was no
PD-123319-sensitive, losartan-insensitive binding and
no [125I]CGP 42112, AT2-selective binding. The total
absence of AT2 receptor binding in the AT2 gene-dis-
rupted mouse was expected, because AT2 receptors are
encoded by a single gene (16, 19, 39), and confirmed the
identity of AT2 receptor binding sites with the cloned
AT2 receptor.
The main finding in our study was the demonstra-
tion of a significant increase in AT1 receptor expression
and mRNA in the kidney of adult AT2 gene-disrupted
mice. Ours is a clear example of how the gene disrup-
tion of one receptor can alter the expression of another
receptor. This is particularly remarkable considering
that the expression of renal AT2 receptors in wild-type
mice is very low, compared with that of AT1 receptors.
Our results further support the hypothesis that the
level of expression of the AT2 receptors inversely cor-
relates with that of AT1 receptors. Earlier studies dem-
onstrated that the cardiac specific over-expression of
AT2 receptors attenuates the AT1-mediated pressor
and chronotropic effects of ANG II (29). In addition,
AT2 receptors are highly expressed in the fetal kidney,
and their numbers decrease during gestation in paral-
lel with a concomitant increase in AT1 receptor expres-
sion (4).
Activation of AT1 and AT2 receptors in wild-type
animals results in effects different, and in most cases
opposite; and stimulation of AT2 receptors was postu-
lated to limit the response of AT1 receptors to ANG II
(17). Stimulation of kidney AT1 receptors decreases
cortical and medullar blood flow and decreases urine
flow and natriuresis, the principal renal effects of ANG
II, shifting pressure natriuresis to the right (11). Con-
versely, in wild-type animals, stimulation of AT2 recep-
tors was reported to increase pressure natriuresis (26)
and their stimulation results in renal vasodilatation,
probably as a consequence of production of cGMP, (42),
nitric oxide (43), and prostaglandin F2 alpha (44), and
increased arachidonic acid release (20). AT1 receptor
blockade produces vasodilatation, diuresis and natri-
uresis, and this was proposed to be due to unopposed
AT2 receptor stimulation (3, 33, 35, 42). The evidence of
a physiological role of renal AT2 receptors, however, is
controversial. AT2 receptor blockade was reported to
potentiate the ANG II-induced PGE2 production after
AT1 receptor stimulation (42) and prevents the effect of
ANG II on the vasculature (24). However, other studies
indicate that chronic blockade of AT2 receptors in wild-
type adult animals does not alter the response to AT1
receptor stimulation by ANG II (33).
In mice lacking AT2 receptor expression there is
increased sodium retention, rightward shift in pres-
sure natriuresis and diuresis, reduction in cortical and
medullar blood flow, increased blood pressure, and
enhanced hypertensive response to ANG II adminis-
tration (12, 15, 17). The phenotype of the AT2 receptor
gene-disrupted mouse may be related to the upregula-
tion of the AT1 receptor, rather than negatively reflect-
ing the actions of the AT2 receptor (12, 45). It is also
possible that the AT2 receptor gene-disrupted pheno-
type could be the result of a lost balance between AT1
and AT2 receptors, with a shift toward predominance of
AT1-related effects. In addition, higher AT1 receptor
transcription and expression could explain the en-
hanced fibrosis after ureteral occlusion in AT2 gene-
deficient mice (25, 28), because kidney fibrosis induced
by ANG II is AT1 receptor dependent (27).
There is a recent report (12) of increased AT1 recep-
tor mRNA in the whole kidney of AT2 gene-disrupted
mice. Our findings of increased AT1 receptor binding
indicate that an actual increase in AT1 receptor expres-
sion occurs in AT2 receptor gene-disrupted mice. In
addition we demonstrate here that upregulation of
renal AT1 receptors predominantly occurs in cortical
structures, the kidney glomeruli, and probably in the
tubular epithelium, and in the outer stripe of the outer
medulla. In AT2 receptor gene-disrupted mice, there
are no changes in AT1 receptor expression in the inner
stripe of the outer medulla. Thus the AT1 upregulation
and the AT2-AT1 feedback in this model are structure
and cell specific. Although the expression of glomerular
and cortical interstitial AT1 receptors may depend on
AT2 receptor expression, the AT1 receptor expression
in the inner stripe of the outer medulla does not. We
conclude from our results that AT1 receptors in renal
glomeruli, interstitial, and medullar cells are differen-
tially regulated.
Last, our findings further support the hypothesis of a
crosstalk or feedback between AT1 and AT2 receptor
subtypes. It appears that AT1 receptors for the most
part do not coexist with AT2 receptors in the same
renal cells. For this reason, the mechanism of feedback
is probably indirect, through modifications in kidney
function related to the absence of AT2 receptors, and
the upregulation of renal AT1 receptors.
In our model, when alterations in the transcription
and expression of AT2 receptors are present from birth,
renal AT1 receptor expression and consequently renal
function, are profoundly affected in the adult. Because
AT1 receptor antagonists are widely used in the treat-
ment of cardiovascular disease, the crosstalk/feedback
between AT1 and AT2 receptors has significant patho-
physiological and clinical relevance.
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